0001432545-16-000002.txt : 20160329 0001432545-16-000002.hdr.sgml : 20160329 20160328183834 ACCESSION NUMBER: 0001432545-16-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160329 DATE AS OF CHANGE: 20160328 EFFECTIVENESS DATE: 20160329 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Orexigen Therapeutics, Inc. CENTRAL INDEX KEY: 0001382911 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 651178822 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-260134 FILM NUMBER: 161533277 BUSINESS ADDRESS: STREET 1: 3344 N. TORREY PINES CT. STREET 2: SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: (858) 875-8600 MAIL ADDRESS: STREET 1: 3344 N. TORREY PINES CT. STREET 2: SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 D 1 primary_doc.xml X0707 D LIVE 0001382911 Orexigen Therapeutics, Inc. 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA CALIFORNIA 92037 (858) 875-8600 DELAWARE None None Corporation true Michael Narachi c/o Orexigen Therapeutics, Inc. 3344 N. Torrey Pines Ct. Ste 200 La Jolla CA CALIFORNIA 92037 Executive Officer Director Thomas Lynch c/o Orexigen Therapeutics, Inc. 3344 N. Torrey Pines Ct. Ste 200 La Jolla CA CALIFORNIA 92037 Executive Officer Thomas Cannell c/o Orexigen Therapeutics, Inc. 3344 N. Torrey Pines Ct. Ste 200 La Jolla CA CALIFORNIA 92037 Executive Officer Preston Klassen c/o Orexigen Therapeutics, Inc. 3344 N. Torrey Pines Ct. Ste 200 La Jolla CA CALIFORNIA 92037 Executive Officer Heather Ace c/o Orexigen Therapeutics, Inc. 3344 N. Torrey Pines Ct. Ste 200 La Jolla CA CALIFORNIA 92037 Executive Officer Louis C Bock c/o Orexigen Therapeutics, Inc. 3344 N. Torrey Pines Ct. Ste 200 La Jolla CA CALIFORNIA 92037 Director Brian H. Dovey c/o Orexigen Therapeutics, Inc. 3344 N. Torrey Pines Ct. Ste 200 La Jolla CA CALIFORNIA 92037 Director David J Endicott c/o Orexigen Therapeutics, Inc. 3344 N. Torrey Pines Ct. Ste 200 La Jolla CA CALIFORNIA 92037 Director Peter K Honig c/o Orexigen Therapeutics, Inc. 3344 N. Torrey Pines Ct. Ste 200 La Jolla CA CALIFORNIA 92037 Director Patrick J Mahaffy c/o Orexigen Therapeutics, Inc. 3344 N. Torrey Pines Ct. Ste 200 La Jolla CA CALIFORNIA 92037 Director Lota S Zoth c/o Orexigen Therapeutics, Inc. 3344 N. Torrey Pines Ct. Ste 200 La Jolla CA CALIFORNIA 92037 Director Eckard Weber c/o Orexigen Therapeutics, Inc. 3344 N. Torrey Pines Ct. Ste 200 La Jolla CA CALIFORNIA 92037 Director Pharmaceuticals Decline to Disclose 06b false 2016-03-21 false true true true true false 0 Leerink Partners LLC 39011 Leerink Partners LLC 39011 1 Federal Street, 37th Fl Boston MA MASSACHUSETTS 02110 CA CALIFORNIA IL ILLINOIS MD MARYLAND MA MASSACHUSETTS NJ NEW JERSEY NY NEW YORK false 329999991 165000000 164999991 The Total Offering Amount includes the aggregate maximum exercise price of warrants to purchase shares of Common Stock of the Issuer. Such warrants have not yet been exercised. false 21 4950000 0 0 false Orexigen Therapeutics, Inc. /s/ Thomas Lynch Thomas Lynch EVP, General Counsel and Secretary 2016-03-28